These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Evaluation of moxifloxacin 0.5% in treatment of nonperforated bacterial corneal ulcers: a randomized controlled trial. Sharma N; Goel M; Bansal S; Agarwal P; Titiyal JS; Upadhyaya AD; Vajpayee RB Ophthalmology; 2013 Jun; 120(6):1173-8. PubMed ID: 23415776 [TBL] [Abstract][Full Text] [Related]
6. Randomized clinical study for comparative evaluation of fourth-generation fluoroquinolones with the combination of fortified antibiotics in the treatment of bacterial corneal ulcers. Shah VM; Tandon R; Satpathy G; Nayak N; Chawla B; Agarwal T; Sharma N; Titiyal JS; Vajpayee RB Cornea; 2010 Jul; 29(7):751-7. PubMed ID: 20489580 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of ofloxacin vs cefazolin and tobramycin in the therapy for bacterial keratitis. Baker RS; Flowers CW; Casey R; Fong DS; Wilson MR Arch Ophthalmol; 1996 May; 114(5):632-3. PubMed ID: 8619784 [No Abstract] [Full Text] [Related]
8. Gatifloxacin 0.3% Versus Fortified Tobramycin-Cefazolin in Treating Nonperforated Bacterial Corneal Ulcers: Randomized, Controlled Trial. Bashir H; Dave A; Mathur U Cornea; 2016 Aug; 35(8):e22-3. PubMed ID: 27227400 [No Abstract] [Full Text] [Related]
9. Clinical efficacy of moxifloxacin in the treatment of bacterial keratitis: a randomized clinical trial. Constantinou M; Daniell M; Snibson GR; Vu HT; Taylor HR Ophthalmology; 2007 Sep; 114(9):1622-9. PubMed ID: 17822972 [TBL] [Abstract][Full Text] [Related]
10. Fourth-generation fluoroquinolones in the treatment of mycobacterial infectious keratitis after laser-assisted in situ keratomileusis surgery. Lee SB; Oliver KM; Strube YN; Mohan SK; Slomovic AR Can J Ophthalmol; 2005 Dec; 40(6):750-3. PubMed ID: 16391641 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of ofloxacin vs cefazolin and tobramycin in the therapy for bacterial keratitis. Report from the Bacterial Keratitis Study Research Group. O'Brien TP; Maguire MG; Fink NE; Alfonso E; McDonnell P Arch Ophthalmol; 1995 Oct; 113(10):1257-65. PubMed ID: 7575256 [TBL] [Abstract][Full Text] [Related]
14. Comparison of topical 0.3% ofloxacin with fortified tobramycin plus cefazolin in the treatment of bacterial keratitis. Panda A; Ahuja R; Sastry SS Eye (Lond); 1999 Dec; 13 ( Pt 6)():744-7. PubMed ID: 10707137 [TBL] [Abstract][Full Text] [Related]
15. Visual recovery in treated bacterial keratitis. Srinivasan M; Mascarenhas J; Rajaraman R; Ravindran M; Lalitha P; Ray KJ; Zegans ME; Acharya NR; Lietman TM; Keenan JD; Ophthalmology; 2014 Jun; 121(6):1310-1. PubMed ID: 24612976 [TBL] [Abstract][Full Text] [Related]
16. The increasing problem of antibiotic resistance. Mamalis N J Cataract Refract Surg; 2007 Nov; 33(11):1831-2. PubMed ID: 17964369 [No Abstract] [Full Text] [Related]